AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

LUMOS DIAGNOSTICS HOLDINGS L

0.070

-0.001-1.41%

Volume:32.42M

Turnover:2.37M

Market Cap:52.40M

PE:-4.99

High:0.078

Open:0.074

Low:0.067

Close:0.071

Loading ...

Overview Company News Filings

Lumos Diagnostics Secures AU$5 Million Loan From Major Shareholders

MT Newswires Live

BRIEF-Lumos Diagnostics Signs Binding Term Sheet For A$5.0 Million Loan Facility

Lumos Diagnostics Holdings Ltd-Proposed Issue of Securities - Ldx

THOMSON REUTERS

Proposed issue of securities - LDX-LDX.AX

Lumos Diagnostics - Lumos Signs Binding Term Sheet for a$5.0 Mln Loan Facility

THOMSON REUTERS

Lumos Diagnostics Holdings Reaches AU$53m Market Cap Benefiting Insider Stock Buying

Simply Wall St.

BRIEF-Lumos Diagnostics Signs Exclusive U.S. Distribution Agreement With Phase Scientific For Febridx

BUZZ-Australia's Lumos Diagnostics soars most in two years on US distribution agreement

Investor Briefing Invitation-LDX.AX

Lumos Diagnostics - Signs Pivotal, Exclusive U.S. Distribution Agreement With Phase Scientific for Febridx

THOMSON REUTERS

Lumos Diagnostics Holdings Ltd - Six-Year Exclusive Agreement Valued at up to US$317 Mln

THOMSON REUTERS

Lumos Diagnostics - Deal for US$2.0 Mln Payable Immediately

THOMSON REUTERS

BRIEF-Lumos Diagnostics Holdings Ltd Says Trading In Securities Will Be Halted Until 15 July Pending Release Of Announcemen

Lumos Diagnostics Holdings Ltd - Trading in Securities Will Be Halted Until 15 July Pending Release of Announcemen

THOMSON REUTERS

Notification of cessation of securities - LDX-LDX.AX

Lumos Receives Research & Development Tax Rebate-LDX.AX

Lumos Enrolls Half of Target Patients Required for Respiratory Test Study; Shares Rise 7%

MT Newswires Live

Lumos Expands US Medicare Coverage for Respiratory Test

MT Newswires Live

Lumos Expands US Medicare Coverage for Respiratory Test; Shares Rise 4%

MT Newswires Live

Lumos Diagnostics Receives Order Worth $126,000 for Respiratory Test; Shares Up 4%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LDX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","market":"AU","secType":"STK","nameCN":"LUMOS DIAGNOSTICS HOLDINGS L","latestPrice":0.07,"timestamp":1752732720000,"preClose":0.071,"halted":0,"volume":32419258,"delay":0,"nameEN":"LUMOS DIAGNOSTICS HOLDINGS L","floatShares":375602340,"shares":748523022,"eps":-0.014041467943630717,"marketStatus":"Not Yet Opened","change":-0.001,"latestTime":"07-17 16:12:00 AEST","open":0.074,"high":0.078,"low":0.067,"amount":2373448,"amplitude":0.15493,"askPrice":0.071,"askSize":100000,"bidPrice":0.07,"bidSize":241428,"shortable":3,"etf":0,"ttmEps":-0.014041467943630717,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1752796800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.071,"openAndCloseTimeList":[[1752710400000,1752732000000]],"volumeRatio":2.4359137523513223,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","floatShares":375602340,"roa":"-13.86%","roe":"-52.41%","lyrEps":-0.028584,"volumeRatio":2.4359137523513223,"shares":748523022,"dividePrice":0,"high":0.078,"amplitude":0.15493,"preClose":0.071,"low":0.067,"week52Low":0.019,"pbRate":"3.47","psRate":"2.32","week52High":0.08,"institutionHeld":0,"latestPrice":0.07,"committee":0.414225,"eps":-0.014041467943630717,"divideRate":0,"volume":32419258,"delay":0,"ttmEps":-0.014041467943630717,"open":0.074,"prevYearClose":0.035,"prevWeekClose":0.029,"prevMonthClose":0.027,"prevQuarterClose":0.027,"fiveDayClose":0.028,"twentyDayClose":0.029,"sixtyDayClose":0.025},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LDX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552105014","title":"Lumos Diagnostics Secures AU$5 Million Loan From Major Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2552105014","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552105014?lang=en_us&edition=fundamental","pubTime":"2025-07-17 14:52","pubTimestamp":1752735172,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  has secured a conditional A$5 million loan facility from major shareholders Tenmile Ventures and Ryder Capital to fund a US Food and Drug Administration waiver for its diagnostic test, according to a Thursday filing with the Australian bourse.The 12-month senior secured loan carries a 15% interest rate, with extension options and repayments tied to product sales. Drawdowns will be at the company's discretion, the filing said.Lumos will simultaneously cancel the unused AU$4 million second tranche of a prior convertible note facility with Lind Global Fund and SBC Global Investment Fund, the filing added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2552917111","title":"BRIEF-Lumos Diagnostics Signs Binding Term Sheet For A$5.0 Million Loan Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2552917111","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552917111?lang=en_us&edition=fundamental","pubTime":"2025-07-17 09:31","pubTimestamp":1752715904,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Signs Binding Term Sheet For A$5.0 Million Loan FacilityJuly 17 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX:LUMOS SIGNS BINDING TERM SHEET FOR A$5.0 MILLION LOAN FACILITYFurther company coverage: LDX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TD0FQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2552176949","title":"Lumos Diagnostics Holdings Ltd-Proposed Issue of Securities - Ldx","url":"https://stock-news.laohu8.com/highlight/detail?id=2552176949","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552176949?lang=en_us&edition=fundamental","pubTime":"2025-07-17 08:12","pubTimestamp":1752711165,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nTUEBRFNSY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2552617931","title":"Proposed issue of securities - LDX-LDX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2552617931","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552617931?lang=en_us&edition=fundamental","pubTime":"2025-07-17 08:12","pubTimestamp":1752711165,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250717:nASXhDdlc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nASX6gNLV6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2552176588","title":"Lumos Diagnostics - Lumos Signs Binding Term Sheet for a$5.0 Mln Loan Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2552176588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552176588?lang=en_us&edition=fundamental","pubTime":"2025-07-17 08:00","pubTimestamp":1752710449,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TD0FQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2552782105","title":"Lumos Diagnostics Holdings Reaches AU$53m Market Cap Benefiting Insider Stock Buying","url":"https://stock-news.laohu8.com/highlight/detail?id=2552782105","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552782105?lang=en_us&edition=fundamental","pubTime":"2025-07-17 04:44","pubTimestamp":1752698660,"startTime":"0","endTime":"0","summary":"Insiders who bought Lumos Diagnostics Holdings Limited ( ASX:LDX ) stock in the last 12 months were richly rewarded...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ldx/lumos-diagnostics-holdings-shares/news/lumos-diagnostics-holdings-reaches-au53m-market-cap-benefiti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2551115875","title":"BRIEF-Lumos Diagnostics Signs Exclusive U.S. Distribution Agreement With Phase Scientific For Febridx","url":"https://stock-news.laohu8.com/highlight/detail?id=2551115875","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551115875?lang=en_us&edition=fundamental","pubTime":"2025-07-16 09:36","pubTimestamp":1752629805,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Signs Exclusive U.S. Distribution Agreement With Phase Scientific For FebridxJuly 16  - Lumos Diagnostics Holdings Ltd LDX.AX:SIGNS PIVOTAL, EXCLUSIVE U.S. DISTRIBUTION AGREEMENT WITH PHASE SCIENTIFIC FOR FEBRIDXSIX-YEAR EXCLUSIVE AGREEMENT VALUED AT UP TO US$317 MILLIONDEAL FOR  US$2.0 MILLION PAYABLE IMMEDIATELYFurther company coverage: LDX.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nFWN3TC19L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2551811346","title":"BUZZ-Australia's Lumos Diagnostics soars most in two years on US distribution agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2551811346","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551811346?lang=en_us&edition=fundamental","pubTime":"2025-07-16 09:21","pubTimestamp":1752628913,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Lumos Diagnostics soars most in two years on US distribution agreement** Shares of Lumos Diagnostics LDX.AX more than double in value to A$0.080** Stock posts its biggest intraday pct gain since July 2023** Healthcare tech co signs U.S. distribution and supply agreement for FebriDx valued at up to $317 million** FebriDx is a rapid point of care test that helps clinicians differentiate between bacterial and non-bacterial acute respiratory infections through a fingerstick blood sample** Agreement signed with Hong Kong-headquartered PHASE Scientific International** About 15.8 million shares change hands, compared with the 30-day average volume of 663,247** YTD, shares up 108.6%  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nL4N3TD02S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2551186031","title":"Investor Briefing Invitation-LDX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2551186031","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551186031?lang=en_us&edition=fundamental","pubTime":"2025-07-16 08:13","pubTimestamp":1752624791,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250716:nASXx2nBl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nASX23gNjv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2551907731","title":"Lumos Diagnostics - Signs Pivotal, Exclusive U.S. Distribution Agreement With Phase Scientific for Febridx","url":"https://stock-news.laohu8.com/highlight/detail?id=2551907731","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551907731?lang=en_us&edition=fundamental","pubTime":"2025-07-16 08:11","pubTimestamp":1752624714,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nFWN3TC19L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2551190775","title":"Lumos Diagnostics Holdings Ltd -  Six-Year Exclusive Agreement Valued at up to US$317 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2551190775","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551190775?lang=en_us&edition=fundamental","pubTime":"2025-07-16 08:11","pubTimestamp":1752624714,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nFWN3TC19L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2551190720","title":"Lumos Diagnostics - Deal for  US$2.0 Mln Payable Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2551190720","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551190720?lang=en_us&edition=fundamental","pubTime":"2025-07-16 08:11","pubTimestamp":1752624714,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nFWN3TC19L:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2550310899","title":"BRIEF-Lumos Diagnostics Holdings Ltd Says Trading In Securities Will Be Halted Until 15 July Pending Release Of Announcemen","url":"https://stock-news.laohu8.com/highlight/detail?id=2550310899","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550310899?lang=en_us&edition=fundamental","pubTime":"2025-07-11 17:59","pubTimestamp":1752227994,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Holdings Ltd Says Trading In Securities Will Be Halted Until 15 July Pending Release Of AnnouncemenJuly 11  - Lumos Diagnostics Holdings Ltd LDX.AX:TRADING IN SECURITIES WILL BE HALTED UNTIL 15 JULY  PENDING RELEASE OF ANNOUNCEMENFurther company coverage: LDX.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250711:nFWN3T70OO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2550006656","title":"Lumos Diagnostics Holdings Ltd -  Trading in Securities Will Be Halted Until 15 July  Pending Release of Announcemen","url":"https://stock-news.laohu8.com/highlight/detail?id=2550006656","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550006656?lang=en_us&edition=fundamental","pubTime":"2025-07-11 13:15","pubTimestamp":1752210954,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250711:nFWN3T70OO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2548586978","title":"Notification of cessation of securities - LDX-LDX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2548586978","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548586978?lang=en_us&edition=fundamental","pubTime":"2025-07-02 10:09","pubTimestamp":1751422161,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250702:nASX53KLHz","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nASX6Fh4GX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2545045939","title":"Lumos Receives Research & Development Tax Rebate-LDX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2545045939","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545045939?lang=en_us&edition=fundamental","pubTime":"2025-06-23 07:01","pubTimestamp":1750633271,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250622:nASX9Brn3m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250622:nASXWr8fJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2540509754","title":"Lumos Enrolls Half of Target Patients Required for Respiratory Test Study; Shares Rise 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540509754","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540509754?lang=en_us&edition=fundamental","pubTime":"2025-06-02 11:44","pubTimestamp":1748835840,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  has enrolled 61 bacterial-positive patients in its clinical study for the company's point-of-care respiratory test, FebriDx, meeting half of the required target, according to a Monday filing with the Australian bourse.The study, aimed at securing a Clinical Laboratory Improvement Amendments  waiver from the US Food and Drug Administration , has enrolled a total of 439 patients, the filing said.Testing of the 500th patient will trigger a $298,457 milestone payment from partner Biomedical Advanced Research and Development Authority, the filing added.The company expects to complete the study and submit its CLIA waiver application to the FDA in the fourth quarter of the year.Its shares rose 7% in recent Monday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU","CLIA"],"gpt_icon":0},{"id":"2538436961","title":"Lumos Expands US Medicare Coverage for Respiratory Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2538436961","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538436961?lang=en_us&edition=fundamental","pubTime":"2025-05-27 13:03","pubTimestamp":1748322237,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  has gained Medicare reimbursement for the company's point-of-care respiratory test, FebriDx, from US Medicare administrative contractor  CGS Administrators, at a rate of $41.38 per test, effective May 1, according to a Tuesday filing with the Australian bourse.The company has now achieved coverage from six of seven MACs, the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","LDX.AU","BK4551","BK7110","BK4080","MAC","MAC.AU","BK7126"],"gpt_icon":0},{"id":"2536547234","title":"Lumos Expands US Medicare Coverage for Respiratory Test; Shares Rise 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536547234","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536547234?lang=en_us&edition=fundamental","pubTime":"2025-05-19 10:16","pubTimestamp":1747620967,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  has gained Medicare reimbursement for the company's point-of-care respiratory test, FebriDx, from US Medicare administrative contractor  WPS Health Solutions, at a rate of $41.38 per test, effective May 1, according to a Monday filing with the Australian bourse.The company has now achieved coverage from five of seven MACs and said negotiations are ongoing with the remaining two.Shares of the company rose 4% in recent Monday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MAC.AU","MAC","BK7126","BK4080","BK7110","BK4551","LDX.AU","BK4231"],"gpt_icon":0},{"id":"2535063874","title":"Lumos Diagnostics Receives Order Worth $126,000 for Respiratory Test; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535063874","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535063874?lang=en_us&edition=fundamental","pubTime":"2025-05-14 11:23","pubTimestamp":1747192994,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics  received the largest single purchase order for the company's point-of-care respiratory test, FebriDx, worth $126,000 from iMedical, according to a Wednesday filing with the Australian bourse.The US Food and Drug Administration cleared FebriDx to be marketed in the US in July 2023 as an aid in diagnosing bacterial acute respiratory infection and distinguishing them from non-bacterial causes, the filing said.Shares rose nearly 4% in afternoon trade Wednesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LDX.AU","BK7126"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":34,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LDX.AU\",params:#limit:5,,,undefined,":[{"date":"2024-07-31","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722384000000,"name":null,"time":"","dateTimestamp":1722348000000,"actualEps":null},{"date":"2024-02-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709074800000,"name":null,"time":"","dateTimestamp":1709038800000,"actualEps":null},{"market":"AU","date":"2023-08-30","symbol":"LDX.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1693317600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LDX.AU\",market:\"AU\",,,undefined,":[]}}